Cerus Corporation

In its fiscal year 2022 Inpatient Prospective Payment System (IPPS) final rule posted 2 August, CMS acknowledged the unprecedented impact of COVID-19 in updating Medicare payment policies and qualit

Cerus Corp. had hoped its blood transfusion protection technology would have gained a more unambiguous endorsement as a core blood safety tool during a US FDA advisory committee meeting, but the mess

With Congress adjourning July 15 for presidential nominating conventions, precious little time is left to iron out House and Senate differences on emergency spending to fight the Zika virus this summe

Face-Pain Implant Trial FDA granted investigational device exemption approval for privately held StimRelieve LLC to launch a study of what the firm says is the world’s smallest percutaneously implanta